Seres Therapeutics (MCRB) Q3 2025 Earnings

Aug 6Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-3.93
-1.37
1.19
3.75

Details

Expected EPS
-2.49
Actual EPS
-2.27
Surprise EPS
0.22
Surprise Percent
+8.84%

Description

⁨Seres Therapeutics⁩ (⁦MCRB⁩) has reported earnings of ⁦-2.27⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts